Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
The French Journal of Urology
|
October 18, 2025
Updated 2025 French guidelines for renal cell carcinoma
Pierre Bigot, Zine-Eddine Khene, Romain Boissier, et al.
Minerva Urology and Nephrology
|
July 13, 2026
Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187)
Léo Schurdi-Levraud, Gaëlle Margue, Arna Geshkovska, et al.
BJU International
|
April 15, 2025
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK)
Adrien Panis, Thibaut Waeckel, Karim Bensalah, et al.
Urologic Oncology
|
February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma
Géraldine Pignot, Pierre Colin, Marc Zerbib, et al.
European Urology Open Science
|
May 31, 2022
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
Magnus Lindskog, Anna Laurell, Anders Kjellman, et al.
Urologic Oncology
|
November 27, 2024
Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157)
Gaëlle Margue, Clément Klein, Bastien Parier, et al.
Clinical Genitourinary Cancer
|
December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)
Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Urologic Oncology
|
September 5, 2025
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)
Caroline Pettenati, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
European Radiology
|
July 19, 2023
Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation
Raphaël Lehrer, Francois Cornelis, Jean-Christophe Bernhard, et al.
European Urology Oncology
|
July 19, 2022
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
Géraldine Pignot, Antoine Thiery-Vuillemin, Laurence Albigès, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
The French Journal of Urology
|
October 18, 2025
Updated 2025 French guidelines for renal cell carcinoma
Pierre Bigot, Zine-Eddine Khene, Romain Boissier, et al.
Minerva Urology and Nephrology
|
July 13, 2026
Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187)
Léo Schurdi-Levraud, Gaëlle Margue, Arna Geshkovska, et al.
BJU International
|
April 15, 2025
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK)
Adrien Panis, Thibaut Waeckel, Karim Bensalah, et al.
Urologic Oncology
|
February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma
Géraldine Pignot, Pierre Colin, Marc Zerbib, et al.
European Urology Open Science
|
May 31, 2022
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
Magnus Lindskog, Anna Laurell, Anders Kjellman, et al.
Urologic Oncology
|
November 27, 2024
Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157)
Gaëlle Margue, Clément Klein, Bastien Parier, et al.
Clinical Genitourinary Cancer
|
December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)
Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Urologic Oncology
|
September 5, 2025
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)
Caroline Pettenati, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
European Radiology
|
July 19, 2023
Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation
Raphaël Lehrer, Francois Cornelis, Jean-Christophe Bernhard, et al.
European Urology Oncology
|
July 19, 2022
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
Géraldine Pignot, Antoine Thiery-Vuillemin, Laurence Albigès, et al.
Page
of 14